查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1753929

2025 年至 2033 年內視鏡逆行性胰膽管攝影市場報告（按產品、程序、最終用戶和地區）

Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球內視鏡逆行性胰膽管攝影市場規模達 17 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 28 億美元，2025-2033 年期間的成長率 (CAGR) 為 5.58%。

內視鏡逆行性胰膽管攝影 (ERCP) 是一種用於診斷和治療肝臟、膽囊、膽管和胰臟異常的影像學技術。它結合了 X 光和一根細長、靈活、輕巧的內視鏡導管，穿過食道、口腔和胃部。它有助於檢測膽管中的阻塞、結石、感染和腫瘤，以及胰管中的液體滲漏。此外，與開放性手術相比，ERCP 的侵入性較小，能夠提供更詳細、更準確的胰膽系統資訊。因此，全球範圍內對用於檢查吞嚥困難、腹瀉、體重減輕、胃灼熱和便血等症狀的內視鏡治療設備的需求正在不斷成長。

內視鏡逆行性胰膽管攝影市場趨勢：

全球人口不斷成長，各種慢性胃腸道 (GI) 和慢性膽道疾病（包括巴雷特病、膽道疾病、肝病、克隆氏症、發炎性腸道疾病、消化性潰瘍以及胃食道逆流症 (GERD)）的盛行率不斷上升，是積極影響市場的關鍵因素之一。此外，良性胰臟和肝臟腫瘤的發生率不斷上升，尤其是在老年族群中，以及全球癌症發生率的不斷上升，正在推動市場發展。同時，醫院和診斷中心的擴張也增加了對影像技術的需求，從而推動了市場成長。此外，各國政府和醫療機構加強對先進內視鏡設備和改善內視鏡研究的投資，也正在增強市場成長。此外，消費者為了快速康復和減少疼痛而越來越傾向於微創手術，以及人們對括約肌切開器等 ERCP 設備的認知度不斷提高，這些都為市場前景帶來了良好的預期。此外，醫療保健基礎設施的持續改善和醫療旅遊業的大幅成長預計將推動市場成長。

本報告回答的關鍵問題

  • 全球內視鏡逆行性胰膽管攝影市場有多大？ 2025-2033年全球內視鏡逆行性胰膽管攝影市場的預期成長率為何？
  • 推動全球內視鏡逆行性胰膽管攝影市場發展的關鍵因素有哪些？
  • COVID-19 對全球內視鏡逆行性胰膽管攝影市場有何影響？
  • 根據產品，全球內視鏡逆行性胰膽管攝影市場是如何分佈的？
  • 根據手術程序，全球內視鏡逆行性胰膽管攝影市場如何分佈？
  • 根據最終用戶，全球內視鏡逆行性胰膽管攝影市場是如何分佈的？
  • 全球內視鏡逆行性胰膽管攝影市場的主要區域有哪些？
  • 全球內視鏡逆行性胰膽管攝影市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球內視鏡逆行性胰膽管攝影市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 內視鏡
  • 內視鏡治療設備
    • 關鍵部分
      • 括約肌切開器
      • 碎石機
      • 支架
      • 其他
  • 可視化系統
  • 能源設備
  • 其他

第7章：市場區隔：依程序

  • 膽道括約肌切開術
  • 膽道支架置入術
  • 膽道擴張
  • 胰臟括約肌切開術
  • 胰管支架置入術
  • 胰管擴張

第8章：市場區隔：按最終用戶

  • 醫院和診所
  • 門診手術中心
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Group Incorporated
    • Fujifilm Holdings Corporation
    • Hobbs Medical Inc.
    • Johnson & Johnson
    • Medi-Globe GmbH
    • Medtronic plc
    • Olympus Corporation
    • Shaili Endoscopy
    • Steris Corporation
    • Telemed Systems Inc.
Product Code: SR112025A6442

The global endoscopic retrograde cholangiopancreatography market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.58% during 2025-2033.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

Endoscopic Retrograde Cholangiopancreatography Market Trends:

The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

Key Market Segmentation:

Breakup by Product:

  • Endoscope
  • Endotherapy Devices
    • Sphincterotomes
    • Lithotripter
    • Stents
    • Others
  • Visualization Systems
  • Energy Devices
  • Others

Breakup by Procedure:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Key Questions Answered in This Report

  • 1.How big is the global endoscopic retrograde cholangiopancreatography market?
  • 2.What is the expected growth rate of the global endoscopic retrograde cholangiopancreatography market during 2025-2033?
  • 3.What are the key factors driving the global endoscopic retrograde cholangiopancreatography market?
  • 4.What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
  • 5.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the product?
  • 6.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the procedure?
  • 7.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the end user?
  • 8.What are the key regions in the global endoscopic retrograde cholangiopancreatography market?
  • 9.Who are the key players/companies in the global endoscopic retrograde cholangiopancreatography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endoscopic Retrograde Cholangiopancreatography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Endoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endotherapy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Sphincterotomes
      • 6.2.2.2 Lithotripter
      • 6.2.2.3 Stents
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Visualization Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Energy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Biliary Sphincterotomy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biliary Stenting
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biliary Dilatation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Sphincterotomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Pancreatic Duct Stenting
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pancreatic Duct Dilatation
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boston Scientific Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 CONMED Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fujifilm Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hobbs Medical Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medi-Globe GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Olympus Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Shaili Endoscopy
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Steris Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Telemed Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Major Drivers and Challenges
  • Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2024
  • Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
  • Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
  • Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 4: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Competitive Structure
  • Table 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Players